Document ID: chunk:federal_register_of_legislation:F2017L00081:reg:19:p2
Version: federal_register_of_legislation:F2017L00081
Segment Type: reg
Provision Reference: reg 19 (pt 2/4)
Character Range: 123249–126723

(CWC Schedule 1B);
 (4) chlorosoman: O‑Pinakolyl methylphosphonochloridate (CAS 7040–57–5) (CWC Schedule 1B);
 (5) DC: Methlyphosphonyl dichloride (CAS 676–97–1) (CWC Schedule 2B); Methylphosphinyldichloride;
 (d) Tear gases and riot control agents including:
 (1) adamsite (Diphenylamine chloroarsine or DM) (CAS 578–94–9); and
 (2) CA (Bromobenzyl cyanide) (CAS 5798–79–8); and
 (3) CN (Phenylacyl chloride or w‑Chloroacetophenone) (CAS 532–27‑4); and
 (4) CR (Dibenz‑(b,f)‑1,4‑oxazephine) (CAS 257–07–8); and
 (5) CS (o‑Chlorobenzylidenemalononitrile or o‑Chlorobenzalmalononitrile) (CAS 2698–41–1); and
 (6) dibromodimethyl ether (CAS 4497–29–4); and
 (7) dichlorodimethyl ether (ClCi) (CAS 542–88–1); and
 (8) ethyldibromoarsine (CAS 683–43–2); and
 (9) bromo acetone; and
 (10) bromo methylethylketone; and
 (11) iodo acetone; and
 (12) phenylcarbylamine chloride; and
 (13) ethyl iodoacetate;
 (e) Defoliants, as follows:
 (1) agent Orange (2,4,5–Trichlorophenoxyacetic acid mixed with 2,4‑dichlorophenoxyacetic acid);
 (2) LNF (Butyl 2‑chloro‑4‑fluorophenoxyacetate);
 (f) Equipment and its components, parts, accessories, and attachments specifically designed or modified for military operations and compatibility with military equipment as follows:
 (1) the dissemination, dispersion or testing of the chemical agents, biological agents, tear gases and riot control agents, and defoliants listed in paragraphs (a), (b), (d) and (e), respectively;
 (2) the detection, identification, warning or monitoring of the chemical agents and biological agents listed in paragraph (a) and (b);
 (3) sample collection and processing of the chemical agents and biological agents listed in paragraph (a) and (b);
 (4) individual protection against the chemical and biological agents listed in paragraphs (a) and (b);
 (5) collective protection against the chemical agents and biological agents listed in paragraph (a) and (b);
 (6) decontamination or remediation of the chemical agents and biological agents listed in paragraph (a) and (b).
 (g) Antibodies, polynucleotides, biopolymers or biocatalysts specifically designed or modified for use with articles controlled in paragraph (f).
 (h) Medical countermeasures, to include pre‑ and post‑treatments, vaccines, antidotes and medical diagnostics, specifically designed or modified for use with the chemical agents listed in paragraph (a) and vaccines with the sole purpose of protecting against biological agents identified in paragraph (b). Examples include: barrier creams specifically designed to be applied to skin and personal equipment to protect against vesicant agents controlled in paragraph (a); atropine auto injectors specifically designed to counter nerve agent poisoning.
 (i) Modelling or simulation tools specifically designed or modified for chemical or biological weapons design, development or employment. The concept of modelling and simulation includes software covered by paragraph (m) specifically designed to reveal susceptibility or vulnerability to biological agents or materials listed in paragraph (b).
 (j) Test facilities specifically designed or modified for the certification and qualification of articles controlled in paragraph (f).
 (k) Equipment, components, parts, accessories, and attachments, exclusive of incinerators (including those which have specially designed waste supply systems and special handling facilities), specifically designed or modified for destruction of the chemical